Finally, correlation analyses revealed significant relationships between serum IL-38 levels and parameters related to liver injury, inflammation, and insulin resistance in individuals with NAFLD or in all participants. This evidence concerns the gene IL1F10 and metabolic dysfunction-associated steatotic liver disease.